The significant tumor response observed following low-dose TRT might be attributed to enhanced extravasation of non-exhausted CAR T cell into the TME (48) and augmented CAR T cell activity, notably IFN-γ production (49), as evidenced in our findings here. This evidence concerns the gene IFNG and neoplasm.